Applied Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary
07/11/2024 17:21
* Applied Therapeutics Inc APLT.OQ reported a quarterly
adjusted
loss of 48 cents per share for the quarter ended September 30,
lower than the same quarter last year, when the company reported
EPS of -47 cents. The mean expectation of five analysts for the
quarter was for a loss of 16 cents per share. Wall Street
expected results to range from -24 cents to -11 cents per share.
* Revenue was $122.00 thousand; analysts expected zero.
* Applied Therapeutics Inc's reported EPS for the quarter
was a
loss of 48 cents.
* The company reported a quarterly loss of $68.59 million.
* Applied Therapeutics Inc shares had risen by 13.5% this
quarter and gained 188.1% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 8.4%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "strong buy"
Wall Street's median 12-month price target for Applied
Therapeutics Inc is $13.00
This summary was machine generated from LSEG data November 7 at
05:21 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.16 -0.48 Missed
Jun. 30 2024 -0.16 0.02 Beat
Mar. 31 2024 -0.16 -0.67 Missed
Dec. 31 2023 -0.23 -0.34 Missed